Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Asymptomatic Intracranial StenosisCognitive ImpairmentCerebrovascular Event
Interventions
DRUG

Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin

First of all, ICAS patients were given health education to exhort them to reduce the risk factors of exposure to stroke and get rid of their unhealthy lifestyles. Secondly, for patients in need, standardize their dosage and course of treatment, mainly including antiplatelet drugs and statins. In addition, patients with diabetes and hypertension urge rational medication to control blood pressure and blood glucose level.

Trial Locations (1)

230032

RECRUITING

Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER